Trial Profile

A Prospective Phase 3 Multi-center Study to Assess the Efficacy and Safety of 18F-mFBG PET Imaging in Subjects With Neuroblastoma

Status: Active, no longer recruiting

Phase of Trial: Phase III

Latest Information Update: 04 Jul 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 18F meta fluorobenzylguanidine (Primary)
Indications Neuroblastoma
Focus Diagnostic use; Registrational
Sponsors Illumina Radiopharmaceuticals

Most Recent Events

03 Apr 2026 Planned End Date changed from 1 May 2024 to 30 Aug 2026.
03 Apr 2026 Status changed from completed to active, no longer recruiting.
07 Oct 2024 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com